Follow
Sagar Salave, Ph.D.
Sagar Salave, Ph.D.
Other namesSagar Salave
Post Doctoral Researcher (University of Kansas-USA)
Verified email at ku.edu - Homepage
Title
Cited by
Cited by
Year
Chitosan: A potential biopolymer in drug delivery and biomedical applications
N Desai, D Rana, S Salave, R Gupta, P Patel, B Karunakaran, A Sharma, ...
Pharmaceutics 15 (4), 1313, 2023
822023
Polysaccharide Based Implantable Drug Delivery: Development Strategies, Regulatory Requirements, and Future Perspectives
S Salave, D Rana, A Sharma, K Bharathi, R Gupta, S Khode, D Benival, ...
Polysaccharides 3 (3), 625, 2022
272022
Systematic development and optimization of teriparatide-loaded nanoliposomes employing quality by design approach for osteoporosis
D Rana, S Salave, S Jain, R Shah, D Benival
Journal of Pharmaceutical Innovation 18 (2), 548-562, 2023
182023
Long-acting parenteral drug delivery systems for the treatment of chronic diseases
AB Jindal, AR Bhide, S Salave, D Rana, D Benival
Advanced Drug Delivery Reviews, 114862, 2023
152023
Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications
B Karunakaran, R Gupta, P Patel, S Salave, A Sharma, D Desai, ...
Vaccines 11 (3), 661, 2023
152023
Peptide functionalised nanocarriers for bone specific delivery of pth (1-34) in osteoporosis
S Salave, D Rana, D Benival
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 11 (3), 142-148, 2021
152021
Versatility of liposomes for antisense oligonucleotide delivery: a special focus on various therapeutic areas
R Gupta, S Salave, D Rana, B Karunakaran, A Butreddy, D Benival, ...
Pharmaceutics 15 (5), 1435, 2023
132023
Anabolic peptide-enriched stealth nanoliposomes for effective anti-osteoporotic therapy
S Salave, D Rana, H Kumar, N Kommineni, D Benival
Pharmaceutics 14 (11), 2417, 2022
132022
Recent trends in drug delivery and emerging biomedical applications of gelatin for ophthalmic indications
D Rana, S Salave, G Rawat, D Benival
Macromolecular Research 30 (10), 687-702, 2022
132022
Nanotherapeutics in tumour microenvironment for cancer therapy
D Rana, S Salave, S Longare, R Agarwal, K Kalia, D Benival
Nanoscience & Nanotechnology-Asia 12 (1), 32-47, 2022
132022
Encapsulation of anabolic peptide in lipid nano vesicles for osteoporosis
S Salave, D Rana, D Benival
Current Protein and Peptide Science 23 (7), 495-503, 2022
122022
Unravelling micro and nano vesicular system in intranasal drug delivery for epilepsy
S Salave, D Rana, R Pardhe, P Bule, D Benival
Pharmaceutical Nanotechnology 10 (3), 182-193, 2022
102022
Collagen-based hydrogels for the eye: A comprehensive review
D Rana, N Desai, S Salave, B Karunakaran, J Giri, D Benival, S Gorantla, ...
Gels 9 (8), 643, 2023
82023
A potential biopolymer in drug delivery and biomedical applications., 2023, 15, 1313
N Desai, D Rana, S Salave, R Gupta, P Patel, B Karunakaran, A Sharma, ...
DOI: https://doi. org/10.3390/pharmaceutics15041313. PMID: https://www. ncbi …, 0
8
Tumor-derived systems as novel biomedical tools—turning the enemy into an ally
N Desai, P Katare, V Makwana, S Salave, LK Vora, J Giri
Biomaterials Research 27 (1), 113, 2023
72023
Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
S Salave, SD Shinde, D Rana, B Sahu, H Kumar, R Patel, D Benival, ...
Pharmaceutics 15 (2), 608, 2023
72023
Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines 2023, 11, 661
B Karunakaran, R Gupta, P Patel, S Salave, A Sharma, D Desai, ...
72023
Quantification of anti-osteoporotic anabolic peptide in stealth lipid nanovesicles through validated rp-hplc method
S Salave, S Jain, R Shah, D Benival
Journal of AOAC International 106 (1), 40-48, 2023
72023
Dual targeting anti-osteoporotic therapy through potential nanotherapeutic approaches
S Salave, D Rana, D Benival
Pharmaceutical Nanotechnology 10 (5), 384-392, 2022
72022
Emerging trends in abuse-deterrent formulations: technological insights and regulatory considerations
D Rana, S Salave, D Benival
Current Drug Delivery 19 (8), 846-859, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20